[1] Hawley D M, Fleischer R C. Contrasting Epidemic Histories Reveal Pathogen-Mediated Balancing Selection on Class II MHC Diversity in a Wild Songbird[J].PLoS One,2012,7(1):e30222.
[2] Zhang M, He H X. Parasite-mediated selection of major histocompatibility complex variability in wild brandt’s voles (Lasiopodomys brandtii) from Inner Mongolia, China[J].BMC Evol Biol,2013,13:149.
[3] Ewald S J, Livant E. Distinctive polymorphism of chicken B-FI (major histocompatibility complex class I) molecules[J].Poult Sci,2004,83(4):600-605.
[4] 戴银,王承志,沈学怀,等.淮南麻黄鸡MHCⅠα链基因的克隆及序列分析[J].动物医学进展,2015,36(2):34-38.
[5] Xu S X, Ren W H, Li S Z, et al. Sequence polymorphism and evolution of three cetacean MHC genes[J].J Mol Evol,2009,69(3):260-275.
[6] Reche P A, Reinherz E L. Sequences variability analysis of human class I and class II MHC molecules: Functional and structural correlates of amino acids polymorphisms[J].J Mol Biol,2003,331(3):623-641.
[7] Cloutier A, Mills J A, Baker A J. Characterization and locus-specific typing of MHC class I genes in the red-billed gull (Larus scopulinus) provides evidence for major, minor, and nonclassical loci vertebrate populations[J].Immunogenetics,2011,63(6):377-394.
[8] Kaufman J, Andersen R, Avila D, et al. Different features of the MHC class I heterodimer have evolved at different rates. Chicken B-F and beta 2-microglobulin sequences reveal invariant surface residues[J].J Immunol,1992,148(5):1532-1546.
[9] 戴银,张丹俊,胡晓苗,等.鸡主要组织相容性复合体Ⅰβ微球蛋白 (β2m)基因的克隆及序列分析[J].中国畜牧兽医,2014,41(10):28-32.
[10] Kozlowski S, Takeshita T, Boehncke W H, et al . Excess beta 2 microglobulin promoting functional peptide association with purified soluble class I MHC molecules[J].Nature,1991,349:74-77.
[11] Gao G F, Tormo J, Gerth U C, et al. Crystal structure of the complex between human CD8 alpha (alpha) and HLA-A2(J)[J].Nature,1997,387:630-634.
[12] Bjorkman P J, Saper M A, Samraoui B, et al. Structure of the human class I histocompatibility antigen, HLA-A2(J)[J].Nature,1987,329:506-512.
[13] 严丹丹,方瑾,宋今丹.不同连接肽的双价单链抗体基因的构建及表达[J].细胞生物学杂志,2007,29(2):272-276.
[14] 闫璐颖,陈建华.张新国.融合蛋白连接肽的研究进展[J].生物技术,2008,18(3):92-94.
[15] 孙鹤,郎志宏,朱莉,等.连接肽在多基因转化中的应用[J].生物技术进展,2011,1(1):21-25.
[16] Argos P. An investigation of oligopeptides linking domains in protein tertiary structures and possible candidates for general gene fusion[J].J Mol Biol,1990,211(4):943-958.
[17] Alfthan1 K, Takkinen K, Sizmann D, et al. Properties of a single-chain antibody containing different linker peptides[J].Protein Engineering,1995,8(7):725-731.
[18] Kikuchi Y, Uno S, Yoshimura Y, et al. A bivalent single-chain Fv fragment against CD47 induces apoptosis for leukemic cells[J].Biochem Biophys Res Commun,2004,315(4):912-918.
[19] Lybarger L, Yu Y Y, Miley M J. Enhanced immune presentation of a single-chain major histocompatibility complex class I molecule engineered to optimize linkage of a C-terminally extended peptide[J].J Biol Chem,2003,278:27105-27111.
[20] 徐杨玉,温世杰,李海芬,等.绿色木霉TvALP-linker-TvRBL 融合基因的构建与原核表达[J].生物技术通报,2015,31(1):131-137.
[21] Goel A,Colcher D,Baranowska-Kortylewicz J, et al. Genetically engineered tetravalent single-chain Fv of the pancarcinoma monoclonal antibody CC49: improved biodistribution and potential for therapeutic application[J].Cancer Research,2000,60:6964-6971.
|